BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.

The BIO International Convention is a comprehensive biotechnology event, bringing together more than 20,000 industry leaders from across the global biotechnology ecosystem. BIO 2026 convenes biotechnology companies, pharmaceutical organizations, academic institutions, investors, non-profit organizations, and government agencies to explore the latest advancements in science, innovation, manufacturing, and commercialization.
ARMI will attend BIO 2026 to connect with stakeholders across the biotechnology community, strengthen existing partnerships, and explore opportunities that support the advancement of regenerative medicine, biomanufacturing, and the development of resilient domestic manufacturing capabilities.